China National Chemical Engineering Crecimiento futuro

Future controles de criterios 1/6

Se prevé un crecimiento anual de los beneficios y los ingresos de China National Chemical Engineering de 16.8% y 14.1% por año respectivamente. Se prevé que el BPA crezca en un 16.8% al año. Se espera que la rentabilidad financiera sea de 11.3% en 3 años.

Información clave

10.6%

Tasa de crecimiento de los beneficios

10.6%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Construction	13.5%
Tasa de crecimiento de los ingresos	10.1%
Rentabilidad financiera futura	10.1%
Cobertura de analistas	Good
Última actualización	27 May 2024

Actualizaciones recientes sobre el crecimiento futuro

China National Chemical Engineering Co., Ltd (SHSE:601117) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

May 02

Recent updates

China National Chemical Engineering Co., Ltd (SHSE:601117) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

May 02

Is China National Chemical Engineering Co., Ltd (SHSE:601117) Worth CN¥6.7 Based On Its Intrinsic Value?

Apr 12

Return Trends At China National Chemical Engineering (SHSE:601117) Aren't Appealing

Mar 21

Here's Why China National Chemical Engineering (SHSE:601117) Can Manage Its Debt Responsibly

Feb 29

Previsiones de crecimiento de beneficios e ingresos

SHSE:601117 - Estimaciones futuras de los analistas y datos financieros pasados (CNY Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
12/31/2026	238,222	7,344	N/A	10,239	9
12/31/2025	220,890	6,871	11,617	8,492	10
12/31/2024	197,684	6,003	9,100	8,811	9
3/31/2024	180,715	5,532	4,772	8,385	N/A
12/31/2023	178,367	5,426	5,800	9,134	N/A
9/30/2023	168,706	5,418	563	4,517	N/A
6/30/2023	173,853	5,713	3,158	6,205	N/A
3/31/2023	165,022	5,549	-675	2,360	N/A
12/31/2022	157,722	5,415	-1,542	1,500	N/A
9/30/2022	167,360	5,486	-3,150	-77	N/A
6/30/2022	156,177	5,381	-5,397	-1,802	N/A
3/31/2022	147,649	4,825	-6,435	-2,486	N/A
12/31/2021	137,293	4,664	-1,590	2,242	N/A
9/30/2021	133,410	3,640	425	3,201	N/A
6/30/2021	128,849	4,003	10,203	12,082	N/A
3/31/2021	121,024	3,802	11,063	12,112	N/A
12/31/2020	109,459	3,516	7,451	8,329	N/A
9/30/2020	106,733	3,390	3,112	4,123	N/A
6/30/2020	101,633	2,904	1,067	2,090	N/A
3/31/2020	99,276	2,968	812	1,833	N/A
12/31/2019	103,624	3,061	3,961	4,724	N/A
9/30/2019	90,753	2,752	4,069	5,052	N/A
6/30/2019	85,954	2,450	-852	60	N/A
3/31/2019	84,246	2,154	1,393	2,335	N/A
12/31/2018	81,445	1,932	3,924	4,909	N/A
9/30/2018	73,848	1,890	4,006	5,313	N/A
6/30/2018	67,636	1,794	6,226	7,604	N/A
3/31/2018	62,975	1,647	2,701	4,240	N/A
12/31/2017	58,571	1,557	N/A	2,886	N/A
9/30/2017	54,906	1,620	N/A	1,062	N/A
6/30/2017	53,198	1,775	N/A	2,520	N/A
3/31/2017	52,539	1,698	N/A	1,993	N/A
12/31/2016	53,076	1,770	N/A	2,833	N/A
9/30/2016	55,307	2,402	N/A	3,233	N/A
6/30/2016	57,331	2,552	N/A	1,509	N/A
3/31/2016	59,074	2,692	N/A	2,682	N/A
12/31/2015	63,532	2,842	N/A	1,903	N/A
9/30/2015	63,312	2,477	N/A	1,845	N/A
6/30/2015	67,157	2,499	N/A	1,578	N/A
3/31/2015	70,326	3,018	N/A	2,063	N/A
12/31/2014	69,256	3,166	N/A	1,482	N/A
9/30/2014	67,461	3,438	N/A	513	N/A
6/30/2014	67,047	3,578	N/A	292	N/A
3/31/2014	63,769	3,417	N/A	553	N/A
12/31/2013	61,728	3,357	N/A	2,069	N/A
9/30/2013	59,977	3,472	N/A	2,467	N/A
6/30/2013	58,181	3,310	N/A	3,233	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (16.8% al año) de 601117 es superior a la tasa de ahorro (2.9%).

Beneficios vs. Mercado: Se prevé que los beneficios (16.8% al año) de 601117 crezcan menos que el mercado CN (24% al año).

Beneficios de alto crecimiento: Se prevé que los beneficios de 601117 crezcan, pero no significativamente.

Ingresos vs. Mercado: Se prevé que los ingresos (14.1% al año) de 601117 crezcan más despacio que el mercado de CN (14.4% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 14.1% al año) de 601117 crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de 601117 sea baja dentro de 3 años (11.3%).

China National Chemical Engineering Crecimiento futuro

Future controles de criterios 1/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Consensus EPS estimates fall by 15%

China National Chemical Engineering Co., Ltd (SHSE:601117) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Price target decreased by 7.2% to CN¥11.61

Price target decreased by 9.1% to CN¥12.89

Price target decreased to CN¥7.80

Price target raised to CN¥8.98

Recent updates

Consensus EPS estimates fall by 15%

China National Chemical Engineering Co., Ltd (SHSE:601117) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Third quarter 2023 earnings released: EPS: CN¥0.13 (vs CN¥0.18 in 3Q 2022)

China National Chemical Engineering Co., Ltd, Annual General Meeting, May 20, 2024

Is China National Chemical Engineering Co., Ltd (SHSE:601117) Worth CN¥6.7 Based On Its Intrinsic Value?

China National Chemical Engineering Co., Ltd to Report Q1, 2024 Results on Apr 29, 2024

Return Trends At China National Chemical Engineering (SHSE:601117) Aren't Appealing

Here's Why China National Chemical Engineering (SHSE:601117) Can Manage Its Debt Responsibly

Investor sentiment improves as stock rises 15%

China National Chemical Engineering Co., Ltd to Report Fiscal Year 2023 Results on Mar 30, 2024

China National Chemical Engineering Co., Ltd to Report Q3, 2023 Results on Oct 28, 2023

Price target decreased by 7.2% to CN¥11.61

Second quarter 2023 earnings released: EPS: CN¥0.30 (vs CN¥0.27 in 2Q 2022)

China National Chemical Engineering Co., Ltd to Report First Half, 2023 Results on Aug 31, 2023

Full year 2022 earnings: EPS and revenues miss analyst expectations

Price target decreased by 9.1% to CN¥12.89

Less than half of directors are independent

Third quarter 2022 earnings released

Second quarter 2022 earnings released: EPS: CN¥0.43 (vs CN¥0.23 in 2Q 2021)

China National Chemical Engineering Co., Ltd (SHSE:601117) announces an Equity Buyback for 61,090,000 shares, representing 1% for CNY 91,000 million.

Less than half of directors are independent

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.16 (vs CN¥0.27 in 3Q 2020)

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Second quarter 2021 earnings released: EPS CN¥0.21 (vs CN¥0.18 in 2Q 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS CN¥0.71 (vs CN¥0.62 in FY 2019)

Price target decreased to CN¥7.80

New 90-day high: CN¥6.63

New 90-day low: CN¥5.48

China National Chemical Engineering Group Corporation Ltd. agreed to acquire 97.94% stake in Huaxu International Financial Leasing Co., Ltd. from China National Chemical Engineering Co., Ltd (SHSE:601117) for approximately CNY 740 million.

China National Chemical Engineering Co., Ltd(XSSC:601117) dropped from FTSE All-World Index (USD)

Sinochem, Chemchina Reportedly Consider Merger Plan That Will Not Raise US National Security Concerns

New 90-day high: CN¥6.06

Revenue and earnings beat expectations

Third quarter 2020 earnings released: EPS CN¥0.27

New 90-day low: CN¥5.29

China National Chemical Engineering Co., Ltd to Report Q3, 2020 Results on Oct 31, 2020

New 90-day low: CN¥5.34

Earnings released

Price target raised to CN¥8.98

China National Chemical Engineering Co., Ltd to Report First Half, 2020 Results on Aug 21, 2020

Previsiones de crecimiento de beneficios e ingresos

Previsiones de crecimiento futuro de los analistas

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

Descubre empresas en crecimiento